18F-fluorocholine PET-guided target volume delineation techniques for partial volume reirradiation in local recurrent prostate cancer

被引：0
|
作者：
Wang, H. [1 ]
Vees, H. [1 ]
Miralbell, R. [1 ]
Wissmeyer, M. [1 ]
Steiner, C. [1 ]
Ratib, O. [1 ]
Senthamizhchelvan, S. [1 ]
Zaidi, H. [1 ]
机构：
[1] Univ Hosp Geneva, Geneva, Switzerland
来源：
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING | 2009年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：S226 / S226
页数：1
相关论文
共 50 条
  • [21] Prognostic value of metabolic parameters and clinical impact of 18F-fluorocholine PET/CT in biochemical recurrent prostate cancer
    Colombie, M.
    Campion, L.
    Bailly, C.
    Rusu, D.
    Rousseau, T.
    Mathieu, C.
    Ferrer, L.
    Rousseau, N.
    Kraeber-Bodere, F.
    Rousseau, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 (12) : 1784 - 1793
  • [22] Evaluation of Prostate Cancer Bone Metastases with 18F-NaF and 18F-Fluorocholine PET/CT
    Beheshti, Mohsen
    Rezaee, Alireza
    Geinitz, Hans
    Loidl, Wolfgang
    Pirich, Christian
    Langsteger, Werner
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57 : 55S - 60S
  • [23] Prognostic value of metabolic parameters and clinical impact of 18F-fluorocholine PET/CT in biochemical recurrent prostate cancer
    M. Colombié
    L. Campion
    C. Bailly
    D. Rusu
    T. Rousseau
    C. Mathieu
    L. Ferrer
    N. Rousseau
    F. Kraeber-Bodéré
    C. Rousseau
    European Journal of Nuclear Medicine and Molecular Imaging, 2015, 42 : 1784 - 1793
  • [24] 18F-Fluorocholine PET/CT in therapeutic strategy of biochemical recurrent prostate cancer: A retrospective study of 200 patients
    Colombie, Mathilde
    Bailly, Clement
    Rusu, Daniela
    Rousseau, Thierry
    Campion, Loic
    Ferrer, Ludovic
    Kraeber-Bodere, Francoise
    Rousseau, Caroline
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [25] 18F-flotufolastat and 18F-rhPSMA-7 PET-guided salvage radiotherapy for recurrent prostate cancer
    Vogel, Marco M. E.
    Gschwend, Juergen E.
    Peeken, Jan C.
    Rauscher, Isabel
    Combs, Stephanie E.
    Eiber, Matthias
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S2383 - S2385
  • [26] Three-phase 18F-fluorocholine PET/CT in the evaluation of prostate cancer recurrence
    Steiner, Ch.
    Vees, H.
    Zaidi, H.
    Wissmeyer, M.
    Berrebi, O.
    Kossovsky, M. P.
    Khan, H. G.
    Miralbell, R.
    Ratib, O.
    Buhegger, F.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2009, 48 (01): : 1 - 9
  • [27] 18F-rhPSMA-7 and 18F-flotufolastat PET-guided salvage radiotherapy in recurrent prostate cancer
    Rauscher, Isabel
    Vogel, Marco
    Gschwend, Juergen
    Peeken, Jan
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [28] Incremental value of integrated 18F-fluorocholine PET/MRI for initial staging of prostate cancer
    Lord, M.
    De Perrot, T.
    Wissmeyer, M.
    Buchegger, F.
    Ratib, O.
    Vallee, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2011, 38 : S110 - S110
  • [29] Pilot comparison of 18F-fluorocholine and 18F-fluorodeoxyglucose PET/CT with conventional imaging in prostate cancer
    Beauregard, J-M
    Williams, S. G.
    DeGrado, T. R.
    Roselt, P.
    Hicks, R. J.
    JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2010, 54 (04) : 325 - 332
  • [30] Significance of 18F-fluorocholine PET/CT positive pulmonary lesions in prostate cancer patients
    Rager, O.
    Baskin, A.
    Amzalag, G.
    Buchegger, F.
    Miralbell, R.
    Ratib, O.
    Zilli, T.
    Garibotto, V.
    NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2015, 54 (05): : 211 - 216
12345